Delayed cardioprotective effects of wy-14643 are associated with inhibition of mmp-2 and modulation of bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia-reperfusion1

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 8, 2013, Pages 608-616

  Barlaka, Eleftheria ^a   Ledvényiová, Veronika ^b   Galatou, Eleftheria ^a   Ferko, Miroslav ^b   Slávka, Čarnická ^b   Ravingerová, Táňa ^b   Lazou, Antigone ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Bax; Bcl 2; Ho 1; Mk886; Mmp 2; Myocardial ischaemia reperfusion; Ppar ; Wy 14643

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; GELATINASE A; HEME OXYGENASE 1; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PROTEIN BCL 2;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION; WISTAR RAT;

EID: 84880714152     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0412     Document Type: Article

References (59)

1. Barger, P.M., and Kelly, D.P. 2000. PPAR Signaling in the control of cardiac energy metabolism. Trends Cardiovasc. Med. 10(6): 238-245. doi:10.1016/ S1050-1738(00)00077-3. PMID:11282301.
2. Baxter, G.F., Goma, F.M., and Yellon, D.M. 1995. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Brit. J. Pharmacol. 115: 222-224. doi:10.1111/j.1476-5381.1995.tb15866.x.
3. Bencsik, P., Kupai, K., Giricz, Z., Gorbe, A., Pipis, J., Murlasits, Z., et al. 2010. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats. Am. J. Physiol. Heart Circ. Physiol. 299(2): H512-H518. doi:10.1152/ajpheart.00052.2010. PMID:20543091.
4. Bulhak, A.A., Jung, C., Ostenson, C.G., Lundberg, J.O., Sjöquist, P.O., and Pernow, J. 2009. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am. J. Physiol. Heart Circ. Physiol. 296(3): H719-H727. doi:10.1152/ajpheart.00394.2008. PMID:19151258.
5. Butts, B.D., Tran, N.L., and Briehl, M.M. 2004. Identification of a functional peroxisome proliferator activated receptor response element in the 3= untranslated region of the human bcl-2 gene. Int. J. Oncol. 24: 1305-1310.PMID: 15067355.
6. Čarnická, S., Adameová, A., Kelly, T., Nemčeková, M., Ferko, M., Mujkošová, J., Galatou, E., Barlaka, E., Lazou, A., and Ravingerová, T. 2012. PPAR-alpha activation protects myocardium against ischemia/reperfusion injury in isolated rat heart. Eur. J. Heart Failure Suppl. 11(Suppl. 1): 404.
7. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., and Evans, R.M. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7: 48-52. doi:10.1038/83336. PMID:11135615.
8. Cheung, P.Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, M.W., and Schulz, R. 2000. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation, 101: 1833-1839. doi:10.1161/01.CIR.101.15.1833. PMID:10769285.
9. Cieslak, D., and Lazou, A. 2007. Regulation of BAD protein by PKA, PKC delta and phosphatases in adult rat cardiac myocytes subjected to oxidative stress. Mol. Cells, 24: 224-231.PMID:17978575.
10. Collino, M., Aragno, M., Mastrocolab, R., Benettia, E., Gallicchioa, M., Dianzania, C., Dannib, O., Thiemermannc, C., and Fantozzia, R. 2006. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/ reperfusion: Effects of the PPAR-α agonist WY14643. Free Radic. Biol. Med. 41(4): 579-589. doi:10.1016/j.freeradbiomed.2006.04.030. PMID:16863991.
11. Crow, M.T., Mani, K., Nam, Y.J., and Kitsis, R.N. 2004. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95: 957-970. doi:10.1161/ 01.RES.0000148632.35500.d9. PMID:15539639.
12. Curtis, M.J. 1998. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc. Res. 39(1): 194-215. doi:10.1016/S0008-6363(98)00083-2. PMID:9764200.
13. Diep, Q.N., Amiri, F., Benkirane, K., Paradis, P., and Schiffrin, E.L. 2004. Longterm effects of the PPAR activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 82(11): 976-985. doi:10.1139/y04-094. PMID:15644937.
14. Dobaczewski, M., Gonzalez-Quesada, C., and Frangogiannis, N.G. 2010. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 48(3): 504-511. doi:10.1016/j.yjmcc.2009.07.015. PMID:19631653.
15. Duann, P., and Lianos, E.A. 2009. GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury. Am. J. Physiol. Renal Physiol. 297: F629-F638. doi:10.1152/ajprenal.00213.2009. PMID:19587144.
16. Ferguson, H.E., Thatcher, T.H., Olsen, K.C., Bates, T.M.G., Baglole, C.J., Kottmann, R.M., Strong, E.R., Phipps, R.P., and Sime, P.J. 2009. Peroxisome proliferator-activated receptor- ligands induce heme oxygenase-1 in lung fibroblasts by a PPAR-independent, glutathione-dependent mechanism. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(5): L912-L919. doi:10.1152/ajplung.00148.2009. PMID:19734319.
17. Gilde, A.J., van der Lee, K.A., Willemsen, P.H., Chinetti, G., van der Leij, F.R., van der Vusse, G.J., Staels, B., and van Bilsen, M. 2003. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 92: 518-24. doi:10.1161/01.RES.0000060700.55247.7C.PMID:12600885.
18. Giricz, Z., Lalu, M.M., Csonka, C., Bencsik, P., Schulz, R., and Ferdinandy, P. 2006. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J. Pharmacol. Exp. Ther. 316: 154-161. doi:10.1124/jpet.105.091140. PMID:16166272.
19. Gottlieb, R.A., and Engler, R.L. 1999. Apoptosis in myocardial ischemiareperfusion. Ann. N.Y. Acad. Sci. 874: 412-426. doi:10.1111/j.1749-6632.1999. tb09255.x. PMID:10415551.
20. Hausenloy, D.J., and Yellon, D.M. 2008. Preconditioning and postconditioning: new strategies for Cardioprotection. Diabetes Obes. Metab. 10(6): 451-459. doi:10.1111/j.1463-1326.2007.00762.x. PMID:17825079.
21. Huss, J.M., and Kelly, D.P. 2004. Nuclear receptor signaling and cardiac energetics. Circ. Res. 95(6): 568-578. doi:10.1161/01.RES.0000141774.29937.e3. PMID: 15375023.
22. ILAR (Institute of Laboratory Animal Resources). 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C. Available from http://www.nap.edu/openbook.php?record_id=5140.
23. Iliodromitis, E.K., Lazou, A., and Kremastinos, D.Th. 2007. Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc. Risk Health Manag. 3: 629-637.PMID:18078014.
24. Imahashi, K., Schneider, M.D., Steenbergen, C., and Murphy, E. 2004. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95: 734-741. doi:10.1161/01.RES.0000143898.67182.4c. PMID:15345651.
25. 2+- superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism, 50(1): 3-11. doi:10.1053/meta.2001.19415. PMID:11172467.
26. Kandasamy, A.D., Chow, A.K., Ali, M.A., and Schulz, R. 2010. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc. Res. 85: 413-423. doi:10.1093/cvr/cvp268. PMID:19656780.
27. Kehrer, J.P., Biswal, S.S., La, E., Thuillier, P., Datta, K., Fischer, S.M., and Vanden Heuvel, J.P. 2001. Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886. Biochem. J. 356: 899-906. doi:10.1042/0264-6021: 3560899. PMID:11389700.
28. Kronke, G., Kadl, A., Ikonomu, E., Bluml, S., Furnkranz, A., Sarembock, I.J., Bochkov, V.N., Exner, M., Binder, B.R., and Leitinger, N. 2007. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc. Biol. 6: 1276-1282. doi:10.1161/ATVBAHA.107.142638. PMID:17413033.
29. L'Abbate, A., Neglia, D., Vecoli, C., Novelli, M., Ottaviano, V., Baldi, S., Barsacchi, R., Paolicchi, A., Masiello, P., Drummond, G.S., McClung, J.A., and Abraham, N.G. 2007. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 293: H3532-H3541. doi:10.1152/ajpheart.00826.2007. PMID:17906103.
30. Lalu, M.M., Csonka, C., Giricz, Z., Csont, T., Schulz, R., and Ferdinandy, P. 2002. Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 296: 937-941. doi:10.1016/S0006-291X(02)02019-3. PMID:12200138.
31. Lazou, A., Iliodromitis, E.K., Cieslak, D., Voskarides, K., Mousikos, S., Bofilis, E., and Kremastinos, D.T. 2006. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2. Apoptosis, 12: 2195-2204. doi:10.1007/s10495-006-0292-5. PMID:17051325.
32. Long, X., Wu, G., Rozanski, D.J., Boluyt, M.O., Crow, M.T., and Lakatta, E.G. 2001. Hypoxia-induced haem oxygenase-1 gene expression in neonatal rat cardiac myocytes. Heart Lung Circ. 10(3): 121-129. doi:10.1046/j.1444-2892.2001.00100.x. PMID:16352050.
33. Lotz, C., Lange, M., Redel, A., Stumpner, J., Schmidt, J., Tischer-Zeitz, T., Roewer, N., and Kehl, F. 2011a. Peroxisome-proliferator-activated receptor _ mediates the second window of anaesthetic-induced preconditioning. Exp. Physiol. 96: 317-324. doi:10.1113/expphysiol.2010.055590. PMID:21123361.
34. Lotz, C., Lazariotto, M., Redel, A., Smul, T.M., Stumpner, J., Blomeyer, C., Tischer-Zeitz, T., Schmidt, J., Pociej, J., Roewer, N., Kehl, F., and Lange, M. 2011b. Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. Exp. Biol. Med. (Maywood), 236: 113-122. doi:10.1258/ebm.2010.010210. PMID:21163821.
35. Markou, T., Dowling, A., Kelly, T., Cieslak, D., and Lazou, A. 2009. Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radic. Res. 43: 809-816. doi:10.1080/10715760903071649. PMID:19568971.
36. Matejikova, J., Kucharska, J., Pinterova, M., Pancza, D., and Ravingerova, T. 2009. Protection against ischemia -induced ventricular arrhythmias and myocardial dysfunction conferred by preconditioning in the rat heart: involvement of mitochondrial K (ATP) channels and reactive oxygen species. Physiol. Res. 58(1): 9-19.PMID:18198991.
37. Murphy, E., and Steenbergen, C. 2007. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol.69: 51-67. doi:10.1146/annurev.physiol.69.031905. 163645. PMID:17007587.
38. Naderi, R., Imani, A., Faghihi, M., and Moghimian, M. 2010. Phenylephrine induces early and late cardioprotection through mitochondrial permeability transition pore in the isolated rat hear t. J. Surg. Res. 164(1): e37-e42. doi:10.1016/j.jss.2010.04.060. PMID:20850771.
39. Ogata, T., Miyauchi, T., Sakai, S., Takanashi, M., Irukayama-Tomobe, Y., and Yamaguchi, I. 2004. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factorkappa- B pathway. J. Am Coll. Cardiol. 43: 1481-1488. doi:10.1016/j.jacc.2003.11.043. PMID:15093887.
40. Paine, A., Eiz-Vesper, B., Blasczyk, R., and Immenschuh, S. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 80(12): 1895-903. doi:10.1016/j.bcp.2010.07.014. PMID:20643109.
41. Peterson, J.T. 2006. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors. Cardiovasc. Res. 69(3): 677-687. doi:10.1016/j.cardiores.2005.11.032. PMID:16413004.
42. Philip, S., Bulbule, A., and Kundu, G.C. 2004. Matrix metalloproteinase-2: Mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj. J. 21: 429-441. doi:10.1007/s10719-004- 5533-7. PMID:15750784.
43. Ravingerova, T., Matejikova, J., Neckair, J., Andelova, E., and Kolair, F. 2007. Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. Mol. Cell. Biochem. 297(1-2): 111-120. doi:10.1007/s11010-006-9335-z. PMID:17016676.
44. Ravingerova, T., Čarnicka, S., Nemčekova, M., Ledvenyiova, V., Adameova, A., Kelly, T., Barlaka, E., Galatou, E., Khandelwal, V.K.M., and Lazou, A. 2012. PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt. Can. J. Physiol. Pharmacol. 90(8): 1135-1144. doi:10.1139/y2012-052. PMID:22809038.
45. Razeghi, P., Young, M.E., Abbasi, S., and Taegtmeyer, H. 2001. Hypoxia in vivo decreases peroxisome proliferator-activated receptor _ -regulated gene expression in rat heart. Biochem. Biophys. Res. Commun. 287(1): 5-10. doi:10.1006/bbrc.2001.5541. PMID:11549245.
46. Rusyn, I., Yamashina, S., Segal, B.H., Schoonhoven, R., Holland, S.M., Cattley, R.C., Swenberg, J.A., and Thurman, R.G. 2000. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res. 60: 4798-4803. PMID:10987289.
47. Sambandam, N., Morabito, D., Wagg, C., Finck, B.N., Kelly, D.P., and Lopaschuk, G.D. 2006. Chronic activation of PPAR-_ is detrimental to cardiac recovery after ischemia. Am. J. Physiol. Heart Circ. Physiol. 290(1): H87-H95. doi:10.1152/ajpheart.00285.2005. PMID:16155108.
48. Sikorski, E.M., Hock, T., Hill-Kapturczak, N., and Agarwal, A. 2004. The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am. J. Physiol. Renal Physiol. 286(3): F425-F441. doi:10.1152/ajprenal.00297.2003. PMID:14761930.
49. Smeets, P.J.H., Planavila, A., Van Der Vusse, G.J., and Van Bilsen, M. 2007. Peroxisome proliferator-activated receptors and inflammation: take it to heart. Acta Physiol. (Oxf.), 191(3): 171-188. doi:10.1111/j.1748-1716.2007.01752.x. PMID: 17935522.
50. Teissier, E., Nohara, A., Chinetti, G., Paumelle, R., Cariou, B., Fruchart, J.C., Brandes, R.P., Shah, A., and Staels, B. 2004. Peroxisome proliferator-activated receptor-γ induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-_ activation properties. Circ. Res. 95: 1174-1182. doi:10.1161/01.RES.0000150594.95988.45. PMID:15539630.
51. Tian, Q., Grzemski, F.A., Panagiotopoulos, S., and Ahokas, J.T. 2006. Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition. Chem. Biol. Interact. 160(3): 241-251. doi:10.1016/j.cbi.2006.02.003. PMID:16540100.
52. Walker, M.J.A., Curtis, M.J., Hearse, D.J., Campbell, R.W.F., Janse, M.J., Yellon, D.M., et al. 1988. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22: 447. doi:10.1093/cvr/22.7.447. PMID:3252968.
53. Wayman, N.S., Hattori, Y., McDonald, M.C., Mota-Filipe, H., Cuzzocrea, S., Pisano, B., et al. 2002. Ligands of the peroxisome proliferator-activated receptors (PPAR- γand PPAR-α) reduce myocardial infarct size. FASEB J. 16(9): 1027-1040. doi:10.1096/fj.01-0793com. PMID:12087064.
54. Yamamura, T., Otani, H., Nakao, Y., Hattori, R., Osako, M., and Imamura, H. 2001. IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 280: H1191-H1200. PMID:11179063.
55. Yang, Q., and Li, Y.H. 2007. Roles of PPARs on regulating myocardial lipid homeostasis. J. Mol. Med. 85(7): 697-706. doi:10.1007/s00109-007-0170-9. PMID: 17356846.
56. Yoshida, T., Maulik, N., Ho, Y.-S., Alam, J., and Das, D.K. 2001. H(mox-1) consti- tutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation, 103: 1695-1701. doi:10.1161/01.CIR.103.12.1695. PMID:11273999.
57. Yue, T.L., Bao, W., Jucker, B.M., Gu, J.-L., Romanic, A.M., Brown, P.J., et al. 2003. Activation of peroxisome proliferator-activated receptor-_ protects the heart from ischemia/reperfusion injury. Circulation, 108(19): 2393-2399. doi:10. 1161/01.CIR.0000093187.42015.6C. PMID:14557369.
58. Yue, T.L., Nerurkar, S.S., Bao, W., Jucker, B.M., Sarov-Blat, L., Steplewski, K., Ohlstein, E.H., and Willette, R.N. 2008. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/ reperfusion injury in Zucker fatty rats. J. Pharmacol. Exp. Ther. 325: 466-474. doi:10.1124/jpet.107.135327. PMID:18287212.
59. Zaugg, M., Lucchinetti, E., Uecker, M., Pasch, T., and Schaub, M.C. 2003. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br. J. Anaesth. 91(4): 551-565. doi:10.1093/bja/aeg205. PMID: 14504159.